Life Sciences

Medtronic marketing investigated

Device Regulation Alert: Safety, Compliance and Reimbursement News, September 15, 2008

Medtronic became the fourth major manufacturer investigated for improperly marketing its bile duct stents, according to an AdvaMed article.

According to the article, Medtronic received a subpoena in late June around the same time as Johnson & Johnson, Boston Scientific, and Abbott Laboratories. The U.S. Attorney in Massachusetts is trying to determine whether the companies promoted the bile duct stents for unapproved use in blood vessels.

Comments

0 comments on “Medtronic marketing investigated

 

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Medical Environment Update

    A subscription to Medical Environment Update pays for itself by saving you time sorting through complex regulations and...

  • Bloodborne Pathogens Training Video

    Meets OSHA requirements for training employees on the bloodborne pathogens standard!

  • Healthcare Marketing Advisor

    Healthcare Marketing Advisor provides concise, time-saving strategies for branding, promoting, and advertising your...

  • Needlestick Prevention Training Video

    Highlighting the five most frequent needlestick scenarios, this training video instructs frontline healthcare staff on on...

Most Popular